Table 4.

Cases of patients with recurrence.

No.	Group	Site of recurrence	Time to recurrence (m)	Management of recurrence	Final outcome
1	UN	Contralateral lobe	49	CT + CCND	NED
2	UN	Contralateral lobe	14	CT + CCND	NED
3	UN	Ipsilateral level VI CLN	10	SND	NED
4	UN	Contralateral lobe	20	CT + CCND	NED
5	UN	Ipsilateral level II-V CLN	71	SND	NED
6	UN	Contralateral lobe, Ipsilateral thyroid bed, bilateral level II-VI CLN	59	CT+SND	NED
7	UN	Contralateral lobe, contralateral level VI CLN	39	CT + CCND	NED
8	UN	Contralateral lobe, contralateral level VI CLN	38	CT + CCND	NED
9	UN	Ipsilateral level II, III CLN	13	SND	NED
10	UN	Contralateral lobe	68	CT + CCND	NED
11	CN	Contralateral lobe	6	CT + CCND	NED
12	CN	Ipsilateral level II-VI CLN	10	SND	NED
13	CN	Contralateral lobe	10	CT + CCND	NED
14	CN	Ipsilateral level II, III, VI CLN	50	CT+SND	NED
15	CN	Contralateral lobe	40	CT + CCND	NED
16	CN	Contralateral lobe	63	CT + CCND	NED
17*	CN	Contralateral lobe	42	CT + CCND	NED

UN, unilateral nodule; CN, contralateral nodule; CT, completion thyroidectomy; CCND, central-compartment neck dissection; SND, selective neck dissection; NED, no evidence of disease.

*Patient No.17 underwent another selective neck dissection 20 months after the second surgery, and there was no evidence of recurrence during the 17-month follow-up period after the third surgery.